Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development, today announced a strategic partnership with the Rosalind & Morris Goodman Cancer Institute ...

In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...

Silicon chips have powered computing for half a century. Increasingly, they are also becoming platforms to read and ...

When scientist J. Craig Venter and his team announced in 2010 that they had created the first cell controlled by a fully synthetic genome, it marked a turning point in how scientists think about life.

Biology — the science of life, living things and the processes that keep us all running — links up in essential ways with many other sciences, such as chemistry, physics and mathematics, which help us ...

We must make sure that synthetic biology is used for the common good–that it puts equity at its heart, that the benefits of synthetic biology are not just available to a small number of people in some ...

Every fall, millions of Americans get their annual flu shots—and while they are at it, they now also get their annual Covid-19 boosters. Already, these shots seem routine; it is easy to forget that ...

This project was supported by Contract No. HQ0034-16-C-0062 between the National Academy of Sciences and the U.S. Department of Defense. Any opinions, findings, conclusions, or recommendations ...

The startup, which operates in the synthetic biology and precision fermentation space, will use the fresh capital to scale ...

When scientist J. Craig Venter and his team announced in 2010 that they had created the first cell controlled by a fully synthetic genome, it marked a turning point in how scientists think about life.